Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bispecific Antibodies in Multiple Myeloma: A Concise Review of Current Treatments.

Cancer investigation·2026
Same author

Automated report-based tracking of pancreatic cysts: implications for guideline-defined growth classification.

Abdominal radiology (New York)·2026
Same author

Targeted Therapies in Non-Small Cell Lung Cancer: A Contemporary Review.

American journal of clinical oncology·2025
Same author

Bruton Tyrosine Kinase Degraders: Current Concepts.

American journal of clinical oncology·2025
Same author

Maintenance Therapy in Acute Myeloid Leukemia.

American journal of clinical oncology·2024
Same author

Inter-reader agreement of the Society of Abdominal Radiology-American Gastroenterological Association (SAR-AGA) consensus reporting for key phenotypes at MR enterography in adults with Crohn disease: impact of radiologist experience.

Abdominal radiology (New York)·2021

Related Experiment Videos

Primary cutaneous anaplastic large-cell lymphoma.

Edward Perry1, Jay Karajgikar, Imad A Tabbara

  • 1Division of Hematology and Oncology, Department of Medicine, George Washington University School of Medicine, Washington, DC.

American Journal of Clinical Oncology
|May 10, 2011
PubMed
Summary

Anaplastic large-cell lymphomas (ALCL) are malignant conditions with distinct systemic and primary cutaneous types. Primary cutaneous ALCL has a high 5-year survival rate due to effective treatments and a relatively benign course.

Related Experiment Videos

Area of Science:

  • Hematology
  • Oncology
  • Dermatology

Background:

  • Anaplastic large-cell lymphomas (ALCL) have been recognized since the 1980s.
  • Distinction between systemic and primary cutaneous ALCL is based on clinical and immunophenotypical findings.
  • Etiologies and pathogeneses of ALCL require further investigation.

Purpose of the Study:

  • To review the current understanding of anaplastic large-cell lymphomas.
  • To highlight the diagnostic and therapeutic advancements in ALCL.
  • To discuss the prognosis and future directions in ALCL research.

Main Methods:

  • Literature review of ALCL diagnosis, presentation, and treatment.
  • Analysis of clinical and immunophenotypical data differentiating ALCL subtypes.
  • Overview of survival rates and therapeutic outcomes for primary cutaneous ALCL.

Main Results:

  • Primary cutaneous anaplastic large-cell lymphoma exhibits a high disease-specific 5-year survival rate of 95%.
  • Effective treatment options and a generally benign disease course contribute to favorable outcomes.
  • Ongoing research focuses on elucidating exact etiologies and pathogeneses.

Conclusions:

  • Significant progress has been made in understanding ALCL since the 1980s.
  • Primary cutaneous ALCL has a favorable prognosis with available treatments.
  • Immunotherapy and biological response modifiers show promise for future ALCL treatment strategies.